PLAT and Stroke: Recombinant t-PA thrombolytic therapy is performed in the management of stroke in adults [15], [16], but in addition to valuable fibrinolytic plasminogen-dependent activity, exogenous t-PA favors post-ichemia hemorrhage transformation, an effect limited by MMP inhibition in animal and in man [17]–[19].